SEC Form 4 · accession 0001225208-16-027758
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard R. DeLuca
Officer — EVP&Pres, Merck Animal Health
Period of report
Feb 22, 2016
Accepted (ET)
Feb 24, 2016 · 12:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 22, 2016 | A | 11,332 | $50.77 | A | 23,583 | D | |
| Common Stock - 401(k) PlanF3 | holding | — | — | — | 803 | I | By 401(k) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards.
- F2Holdings include shares acquired in dividend reinvestment transactions.
- F3Includes shares acquired and dividends earned through January 8, 2016, in the Merck U.S. Savings Plan, a 401(k) plan.